Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantSelf-StudyKey Populations
Sign In or Register to get started
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 3 Overview
HIV in Women - 0%Topic 1
BackgroundActivities - 0%Topic 2
HIV Epidemiology in WomenActivities - 0%Topic 3
Antiretroviral Therapy in WomenActivities - 0%Topic 4
Contraception in Women with HIVActivities - 0%Topic 5
Contraception Considerations for Women at Risk for HIVActivities - 0%Topic 6
Serodifferent Couples Desiring PregnancyActivities - 0%Topic 7
Vaginitis in Women with HIVActivities - 0%Topic 8
Intimate Partner Violence in Women with HIVActivities - 0%Topic 9
Menopause in Women with HIVActivities - 0%Topic 10
Summary PointsActivities - HIV in Women CE Quiz
HIV in Women Overview
About this Lesson
Last Updated: February 3rd, 2025
CNE/CME Continuing Education
This lesson qualifies for:
View CE Notices
- 1.5 CME AMA PRA Category 1 Credits™, or
- 1.5 CNE contact hours and 1.5 CE contact hours (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: September 17th, 2018
CNE and CME Review: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to Acquire CE for this Lesson:
1
Quiz
Score 80%+
2
Give Feedback
Complete survey
3
Print CE Certificate
Obtain proof of CE3rd Edition
This is a substantial revision of the original Lesson. The previous edition was titled HIV in Women and available until September 1st, 2023.
Learning Objectives
- Describe key epidemiologic features of women with HIV in the United States
- Summarize contraception options and recommendations for women with HIV
- Discuss recommended antiretroviral regimens for women who may become pregnant
- Identify conception strategies for heterosexual HIV-serodifferent couples desiring pregnancy
- List appropriate steps for evaluation and management of vaginal discharge
Lesson Contributors
Authors
Hillary K. Liss, MD
Hillary K. Liss, MD
Clinical Associate Professor of Medicine
Division of General Internal Medicine
University of Washington
Clinical Associate Professor of Medicine
Division of General Internal Medicine
University of Washington
Disclosures:
None
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Reviewers
Aley G. Kalapila, MD, PhD
Aley G. Kalapila, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Disclosures:
None
Lesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Question Bank
Interactive board-review style questions about Epidemiology of HIV.
CNE/CME CME+MOC credits and CNE contact hours available.